Annual Debt To Equity
0.02
0.000.00%
31 December 2023
Summary:
Inhibikase Therapeutics annual debt to equity ratio is currently 0.02, unchanged on 31 December 2023. During the last 3 years, it has fallen by -0.01 (-33.33%). IKT annual debt to equity is now -33.33% below its all-time high of 0.03, reached on 31 December 2020.IKT Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Debt To Equity
-0.27
-0.30-1000.00%
30 September 2024
Summary:
Inhibikase Therapeutics quarterly debt to equity ratio is currently -0.27, with the most recent change of -0.30 (-1000.00%) on 30 September 2024. Over the past year, it has dropped by -0.29 (-1450.00%). IKT quarterly debt to equity is now -280.00% below its all-time high of 0.15, reached on 31 March 2021.IKT Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKT Debt To Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | 0.0% | -1450.0% |
| 3 y3 years | -33.3% | -2800.0% |
| 5 y5 years | +106.7% | - |
IKT Debt To Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -33.3% | +100.0% | -1000.0% | at low |
| 5 y | 5 years | -33.3% | +106.7% | -280.0% | at low |
| alltime | all time | -33.3% | +106.7% | -280.0% | at low |
Inhibikase Therapeutics Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -0.27(-1000.0%) |
| June 2024 | - | 0.03(0.0%) |
| Mar 2024 | - | 0.03(+50.0%) |
| Dec 2023 | 0.02(0.0%) | 0.02(0.0%) |
| Sept 2023 | - | 0.02(0.0%) |
| June 2023 | - | 0.02(+100.0%) |
| Mar 2023 | - | 0.01(-50.0%) |
| Dec 2022 | 0.02 | 0.02(+100.0%) |
| Sept 2022 | - | 0.01(>+9900.0%) |
| June 2022 | - | 0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 0.00(-100.0%) |
| Dec 2021 | 0.01(-66.7%) | 0.01(0.0%) |
| Sept 2021 | - | 0.01(0.0%) |
| June 2021 | - | 0.01(-93.3%) |
| Mar 2021 | - | 0.15(+400.0%) |
| Dec 2020 | 0.03(-137.5%) | 0.03(-121.4%) |
| Sept 2020 | - | -0.14(0.0%) |
| June 2020 | - | -0.14(0.0%) |
| Mar 2020 | - | -0.14(+75.0%) |
| Dec 2019 | -0.08(-73.3%) | -0.08 |
| Dec 2018 | -0.30 | - |
FAQ
- What is Inhibikase Therapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics annual debt to equity year-on-year change?
- What is Inhibikase Therapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics quarterly debt to equity year-on-year change?
What is Inhibikase Therapeutics annual debt to equity ratio?
The current annual debt to equity of IKT is 0.02
What is the all time high annual debt to equity for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high annual debt to equity ratio is 0.03
What is Inhibikase Therapeutics annual debt to equity year-on-year change?
Over the past year, IKT annual debt to equity ratio has changed by 0.00 (0.00%)
What is Inhibikase Therapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of IKT is -0.27
What is the all time high quarterly debt to equity for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high quarterly debt to equity ratio is 0.15
What is Inhibikase Therapeutics quarterly debt to equity year-on-year change?
Over the past year, IKT quarterly debt to equity ratio has changed by -0.29 (-1450.00%)